Venous hemangioma

Overview

Diagnosis

Management

Special Populations

Key Recommendations

References

Showing 100 most recent of 4380 indexed papers.

1 Burnett AE, Lech TK, McCarthy S, Silvari V. Antithrombosis stewardship across the care spectrum: optimizing transitions in venous thromboembolism. Journal of thrombosis and haemostasis : JTH 2026. link 2 Shafieqa N, Koothan V, Prasad Thangarasu K, Ks S. Pulmonary embolism in a post laparoscopic hysterectomy for endometrial cancer: defying thromboprophylaxis. BMJ case reports 2026. link 3 Dunn A. In provoked VTE with ≥1 enduring risk factor, extending anticoagulation with apixaban reduced symptomatic recurrent VTE at 12 mo. Annals of internal medicine 2026. link 4 Amer M, Alhazzani W, Møller MH, Al-Suwaidan FA, Alshahrani M. Bridging practice and evidence: insights from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine and Saudi Critical Care Society Guidelines on trauma-related VTE. Scandinavian journal of trauma, resuscitation and emergency medicine 2026. link 5 Adeli S. Impact of multilayer compression bandages on subdressing pressure generated by a sNPWT: an experimental study. Journal of wound care 2026. link 6 Fleischhauer T, Sander N, Feisst M, Awounvo S, Weller L, Poss-Doering R et al.. Treating Venous Leg Ulcers in Primary Care: The Cluster-Randomized Ulcus Cruris Care Trial. Deutsches Arzteblatt international 2026. link 7 Michelucci A, Salvia G, Janowska A, Granieri G, Morganti R, Dini V et al.. Fluorescence-Based Evaluation of Bacterial Load in Perilesional Skin: A Comparison Between Short Stretch Bandage and Zinc Oxide Bandage. The international journal of lower extremity wounds 2026. link 8 Rerkasem A, Nantakool S, Kulprachakarn K, Rojawat C, Ounjaijean S, Pongtam S et al.. The Effect of Standard Compression Adjuvant with a Tailored Exercise Training Program on Health-Related Quality of Life Outcomes in Treating Adults with Venous Leg Ulcer: A Randomized Controlled Trial. The international journal of lower extremity wounds 2026. link 9 Rossi FH, Kambara AM. Paradigm shift and long-term results in the diagnosis and treatment of pelvic venous disorder. Journal of vascular surgery. Venous and lymphatic disorders 2026. link 10 Gomes FJP, Baixinho CL, Monteiro AIC, da Costa AS, Henriques MAP. Nurses' Perceptions of Fundamental Care in Preventing Venous Ulcer Recurrence: A Qualitative Focus Group Study. International wound journal 2026. link 11 Zhou Y, Zhan X, Qiao T. Development and Validation of a Predictive Model for Poor Healing After Great Saphenous Vein Stripping in Patients With Varicose Ulcers: Focusing on Preoperative Iron Metabolism Markers. Annali italiani di chirurgia 2026. link 12 Toz H, Kuserli Y, Türkyılmaz G, Türkyılmaz S, Kavala AA. Comparison of high-pressure compression stockings and compression bandages for ulcer treatment in venous ulcer patients. Vascular 2026. link 13 Alkahtani AM, Dumville J, Mott L, Armitage C. Barriers to and enablers of prophylactic compression use by people at risk of venous leg ulcer recurrence: a qualitative study. BMJ open 2026. link 14 Zhou P, Wang X, Gu F, Huang Z, Yu J, Li M. Preferences of continuous care service options for patients with venous leg ulcer development of attributes for discrete choice experiments. Vascular 2026. link 15 Ascher AN, Ascher E, Hingorani A, Fang J. Proximal tumescence during treatment of saphenous veins with polidocanol endovenous microfoam provides successful ablation of larger veins and predicts reduced microfoam volume. Journal of vascular surgery. Venous and lymphatic disorders 2026. link 16 Arnold K, Bernstein Z, Hughes E. Thromboprophylaxis for Prevention of Venous Thromboembolism: Practice Patterns Among American Head and Neck Society Members. The Annals of otology, rhinology, and laryngology 2026. link 17 Kang F, Wang Y, Cai F, Wu L, Han L, Yin Q et al.. Disproportionality analysis of fondaparinux associated adverse events based on the FDA adverse event reporting system. PloS one 2026. link 18 Şahinbaş M, Şahinbaş B, Ağadayı E. Thrombotic and Hemorrhagic Adverse Events of Direct Oral Anticoagulants: An Analysis of Sex-Related Differences Using Food and Drug Administration Adverse Event Reporting System. Anatolian journal of cardiology 2026. link 19 Guo G, Ye L, Chen T, Zhou J, Niu P, Zeng X et al.. Pharmacokinetic prediction and dosage adjustment of enoxaparin administration in pregnant women with renal insufficiency: A FAERS-PBPK modeling study. Journal of pharmaceutical sciences 2026. link 20 Tafur AJ, Brenner B, Demelo-Rodríguez P, Guirado L, Pedrajas JM, Mazzolai L et al.. Venous Thromboembolism Outcomes by Geographic Region and Self-Reported Race: Insights from the RIETE Registry. Thrombosis and haemostasis 2026. link 21 Lonnberg F, Siddiqui AJ. Risk of cardiovascular events in patients diagnosed with venous thromboembolism. The American journal of medicine 2026. link 22 Cahill M, O'Shaughnessy F, Boland F, Ainle FN, Donnelly J, Cullinan S et al.. Accuracy, Efficiency, and usability of a Semi-Automated SMART on FHIR venous thromboembolism risk assessment App: A randomised crossover simulation study. International journal of medical informatics 2026. link 23 Rath W, Tsikouras P, Pecks U. Recommendations from guidelines for the prevention of venous thromboembolism in pregnant women with inherited thrombophilia. Archives of gynecology and obstetrics 2026. link 24 Llobet D, Mojal S, Vallvé C, Carrasco M, Vilalta N, Mateo J et al.. The von Willebrand factor/ADAMTS13 ratio as an indicator of venous thromboembolism risk: results from the RETROVE project. Journal of thrombosis and thrombolysis 2026. link 25 De Corte P, Klinghardt M, Bauerfeind A, Boehnke T, Heinemann K. Risk of venous thromboembolism associated with chlormadinone acetate- and levonorgestrel-containing combined oral contraceptives - Insights from the retrospective RIVET-RCS study. Contraception 2026. link 26 Lin DS, Lo HY, Huang KC, Lin TT, Lee JK, Lin LY. Long-term exposure to air pollution and the risks of venous thromboembolism: a nationwide population-based retrospective cohort study. Clinical research in cardiology : official journal of the German Cardiac Society 2026. link 27 Gou Y, Li DD, Li X, Yuan X, Wang YH, Yang JZ et al.. Integrated metabolomics and proteomics to screen early diagnostic biomarkers of venous thromboembolism following severe trauma: A retrospective study. Injury 2026. link 28 Khaw KL, Jones I, Fisher AH, Hunter K, Bonawitz SC. Evaluating the Merit and Applications of the Caprini Risk Score as a Complications Predictor. Journal of reconstructive microsurgery 2026. link 29 Pititto GN, Maraziti G, Squizzato A, Becattini C. Direct Oral Anticoagulants for Prevention of Venous Thromboembolism after Cancer-Related Surgery: Systematic Review and Network Meta-Analysis. Thrombosis and haemostasis 2026. link 30 Esposito DV, Sobrinho HFS, Marques MR. A non-coding ABO regulatory variant associated with VWF levels, thrombosis risk, and COVID-19 severity is topologically linked to ADAMTS13 in endothelial cells. HGG advances 2026. link 31 Jreij G, Crone C, Wiley A, Kankaria A, Lin MS, Mayorga-Carlin M et al.. Meta-analysis of duration of venous thromboembolism risk following hospitalization in surgical and medical patients. Journal of vascular surgery. Venous and lymphatic disorders 2026. link 32 Bitonti TM, Durr KM, Fernando SM, Rochwerg B, Carrier M, Siegal DM et al.. Randomised controlled trials for the prevention of venous thromboembolism in critically ill patients: A systematic review of sample size methodologies. Anaesthesia and intensive care 2026. link 33 Al Dawood R, Sabah HA, Mathews N, Douketis J, Hayward C. A Retrospective Study of Adult and Pediatric D-Dimer Tests to Identify Opportunities for Improved Utilization. International journal of laboratory hematology 2026. link 34 Santos R, Wing S, Martinez M. Dural Sinus Malformation Involving a Persistent Transtentorial Sinus: A Rare Variant. Journal of child neurology 2026. link 35 Evans A, Eastman M, Dykes PC, Jones BE, Sather J, Geppert J. Natural Language Processing in Clinical Quality Measures of Diagnostic Performance: Learnings from Three Case Reports. Joint Commission journal on quality and patient safety 2026. link 36 Bhat R, Sharathkumar A, Kumar R, Corrales-Medina FF, van Ommen H, Bhatt M et al.. Frequency of, and prognostic factors for, residual thrombosis and complete veno-occlusion following anticoagulation for provoked venous thromboembolism in patients <21 years: findings from the Kids-DOTT Multinational Trial. Journal of thrombosis and haemostasis : JTH 2026. link 37 Turrini M, Valenti R, Ladegaard Knox JB, NKosi Rio AZ, Svendsen MN, Bourgain C. Beyond Preferences: Rethinking shared decision-making through the Lens of care. Social science & medicine (1982) 2026. link 38 Rigney BP, Storme JG, Garbuz DS, Sheridan GA. Persistent Lack of International Consensus for Venous Thromboembolism Prophylaxis Recommendations following Total Hip Arthroplasty. The Journal of arthroplasty 2026. link 39 Zeng Z, Bea S, Sreedhara SK, Bykov K. Comparative risk of nonvertebral fractures associated with oral anticoagulants in patients with venous thromboembolism. American journal of epidemiology 2026. link 40 Chang CY, Hsu CP, Cheng CT, Chen DY, Hsieh MJ, Hsieh IC et al.. Retrospective cohort analysis of low-molecular-weight heparin versus non-vitamin K antagonist oral anticoagulants for venous thromboembolism prophylaxis across racial groups in hospitalized trauma patients. International journal of surgery (London, England) 2026. link 41 Mitic MM, Usjak D, Kovac M, Basaric D, Manevski SD, Stikic MC et al.. Exploring genetic drivers of unexplained venous thromboembolism through whole-exome sequencing. Thrombosis research 2026. link 42 Gurumurthy G, Kisiel F, Reynolds L, Thomas W, Othman M, Arachchillage DJ et al.. Machine Learning in Venous Thromboembolism-Why and What Next?. Seminars in thrombosis and hemostasis 2026. link 43 Smit ER, Poolen GC, van Duijl TT, Cannegieter SC, Muñoz Sandoval D, van der Zwaan C et al.. Plasma proteomics does not identify biomarkers of venous thromboembolism recurrence during and after anticoagulation: results from the VISTA study. Journal of thrombosis and haemostasis : JTH 2026. link 44 Eck R, Granholm A, Tøgern A, Jensen AKG, Jonmarker S, Sjövall F et al.. Low-Molecular-Weight Heparin for Adult ICU Patients Who Require Thromboprophylaxis: Protocol for the INCEPT-Thromboprophylaxis Platform Trial Domain. Acta anaesthesiologica Scandinavica 2026. link 45 Dix C, Breen K, Robinson S, McCormick A, Hunt BJ. Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency. Journal of thrombosis and haemostasis : JTH 2026. link 46 Khasnavis S, Moon JY, Leiderman E. Overview of direct oral anticoagulation trends in the Bronx: case control study of patient and systemic factors in medication non-adherence. Open heart 2026. link 47 Chagas J, Almeida Oliveira J, Oliveira ECF, Braga Andrade Martins G, Ribeiro de Oliveira F, Ribeiro DD et al.. The impact of hormonal intrauterine device use on health-related quality of life in women with a history of venous thromboembolism: a systematic review. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2026. link 48 Zhang Q, Yao Y, Wei Y, Sun Y, Zhu S, Yi L et al.. Independent and Joint Associations of Circadian Rhythm Patterns and Physical Activity Levels With Venous Thromboembolism: A Large-Scale Cohort Study Using Accelerometry Measurements. Journal of physical activity & health 2026. link 49 Larouche A, Dollo V, Mercier G, Singbo N, Éthier C, Boulanger MC et al.. Impact of Obesity and Overweight on Heparin Dosing and Clinical Outcomes in Pediatric Patients with Venous Thromboembolism. Thrombosis and haemostasis 2026. link 50 Mahé I, Chapelle C, Girard P, Carrier M, Palomares LJ, Samama CM et al.. Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial. The Lancet. Haematology 2026. link00291-1) 51 Xie Y, Zhou J, Zhu Y, Xie Y. The impact of different intensities of physical activity on the risk of venous thromboembolism: A Mendelian randomization study. Medicine 2026. link 52 Alam U, Ali MA, Ansab M, Rath S, Khattak F, Bacha Z et al.. Extended reduced versus full-dose treatment with factor Xa inhibitors in patients with venous thromboembolism: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Naunyn-Schmiedeberg's archives of pharmacology 2026. link 53 Xiang S, Wang X. A Review of the Effectiveness and Safety of Catheter-Directed Thrombolysis for Venous Thromboembolism. Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2026. link 54 Butler AS, Cole S, Arya R, Patel JP. Considerations of safety for women prescribed apixaban or rivaroxaban who breastfeed-a physiologically based pharmacokinetic analysis. Journal of thrombosis and haemostasis : JTH 2026. link 55 Bilal AR, Umar SA, Arfin SMW, Bilal AR, Sajid M, Gaba H et al.. Efficacy and safety of reduced-dose versus full-dose DOACs in extended treatment of VTE: A systematic review and meta-analysis. Journal of thrombosis and thrombolysis 2026. link 56 Borazjani R, Khorram R, Ghorbani M, Mohammadi M, Nerys-Figueroa J, Kachooei AR et al.. Aspirin Versus Other Anticoagulants for the Initial Prevention of Venous Thromboembolism Following Elective Total Hip and Knee Arthroplasty: An Umbrella Review and Meta-Analysis. The Journal of arthroplasty 2026. link 57 de Oliveira Buril G, Portugal MF, Neves S, da Silva VS, Sad EF, Caffaro RA et al.. Venous Thromboembolism in Patients Receiving Rivaroxaban Plus Aspirin or Standard Treatment after Lower Limb Revascularization-Rationale and Design of the RESOLUTION Trial. Annals of vascular surgery 2026. link 58 Ross KR, Throckmorton SK, Haley KM, Small A, Mengden S, Tiwari N et al.. Blue Nodules in a 2-Year-Old Female With Chronic Severe Anemia. International journal of dermatology 2026. link 59 Haas J, Zhou T, Yuen K, Retrouvey H, Douketis J, Ghumman A. National survey of thromboprophylaxis management and tranexamic acid utilization in patients undergoing non-free flap breast surgery. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2026. link 60 Chan RR, Hamid E, Le T, Alaverdashvili M, Wanson A, Halpape K. Bridging the mind and body: exploring venous thromboembolism in psychiatric inpatients. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists 2026. link 61 Zhang X, Liu J, Wei J, Lin C, Yang W, Wang M et al.. Implementation outcomes of a VTE prevention and management system within the close-knit county medical alliance model. Frontiers in public health 2026. link 62 Silva H, Rezendes C. Quantifying superficial vein morphology with near-infrared imaging during venous congestion. Phlebology 2026. link 63 Brown A, Li ES, Patel S, Massie A, Ihunwo P, Schaap A et al.. Efficacy and safety of direct oral anticoagulants versus enoxaparin for extended thromboprophylaxis following sleeve gastrectomy. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2026. link 64 Raad MK, Prozora S, Faustino EVS. Absolute time-dependent risk of hospital-acquired venous thromboembolism in children. Thrombosis research 2026. link 65 Kamada K, Fukaya E, Iwata E, Uchida D, Mo M, Hanzawa K et al.. Disaster-associated venous thromboembolism countermeasures in Japan: Insights from past major earthquakes. Journal of vascular surgery. Venous and lymphatic disorders 2026. link 66 Yuksel B, Karadag Arli S. Nurses' knowledge and practice in Venous Thromboembolism prevention: Development and validation of a scale. Nurse education in practice 2026. link 67 Alenichev AV, Chubchenko SV, Gavrilov SG. Iliac vein stent placement in the treatment of pelvic venous disorders in women: A systematic review. Phlebology 2026. link 68 Ma J, Tang H, Zhang Y, Yi X, Zhong T, Li X et al.. Machine Learning for Predicting Venous Thromboembolism After Joint Arthroplasty: Systematic Review of Clinical Applicability and Model Performance. JMIR medical informatics 2026. link 69 Gmeiner J, Kaiser R, Fischer J, Krächan A, Wasner L, Marchant Seiter T et al.. Thromboembolic Risk among Patients on Dual Antiplatelet Therapy with or without Heparin Thromboprophylaxis. Thrombosis and haemostasis 2026. link 70 Munda E, Rhoades R. Clinical utility and costs of inpatient hereditary thrombophilia testing following acute VTE: A 5-Year retrospective study. Journal of thrombosis and thrombolysis 2026. link 71 Kido K, Shimizu M, Shiga T, Hashiguchi M. Evaluating the Concomitant Use of Diltiazem or Verapamil With Direct Oral Anticoagulants: A Meta-analysis. The Annals of pharmacotherapy 2026. link 72 Didembourg M, Morimont L, De Gottal E, Douxfils J. The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum. Thrombosis research 2026. link 73 Antoun C, Oto J, Herranz R, Medina P, Morelli VM, Hveem K et al.. Plasma miR-145-5p levels and risk of cancer-associated thrombosis-results from the HUNT study. Journal of thrombosis and haemostasis : JTH 2026. link 74 Wang C, Wu X, Wang J, Fei B, Jiang H. Investigating the association between gut microbiota and venous thromboembolism mediated by immune cells: A mediation Mendelian randomization study. Medicine 2026. link 75 Sochet AA, Le MQ, Goldenberg NA, Betensky M. Thrombolytic Instillation for Central Venous Catheter Dysfunction and Venous Thromboembolism Risk Among Critically Ill Children. Seminars in thrombosis and hemostasis 2026. link 76 Gurunathan U, Bright M, Mullany D, Judd M, Hay K, Nandurkar H et al.. Impact of extended duration pharmacological thromboprophylaxis on venous thromboembolism after hip and knee arthroplasty and hip fracture surgery: a systematic review and meta-analysis of randomised controlled trials. Journal of thrombosis and thrombolysis 2026. link 77 Li TH, Wang YW, Feng JX, Sun N, Bian YJ, Ma JY et al.. Qualitative analysis of out-of-hospital self-management capabilities and ongoing care needs in patients with gynecological malignancies and venous thromboembolism. Annals of medicine 2026. link 78 Shea J, Ghosh A, Turner BR, Davies AH, Onida S. A systematic review and meta-analysis of venous thromboembolism risk in surgical patients with recent air travel. Phlebology 2026. link 79 Jackson A, Humes DJ, Mehrkar A, Bacon SCJ, Davy S, Goldacre B et al.. Venous thromboembolism risk following surgery during the COVID-19 pandemic. Anaesthesia 2026. link 80 Alanizi AH, Alanazi NH, Bin Makhash AS, Alotibi RH, Qubaiban RM, Badawoud AM et al.. Use of Apixaban for Venous Thromboembolism Prophylaxis in an Older Hemodialysis Patient After Total Knee Replacement: A Case Report. The American journal of case reports 2026. link 81 Zhang Z, Jin Z, Wang H, Zhang H, Liu B, Wang H et al.. Smart Technology-Assisted Patient-Centered Management in Venous Thromboembolism: Pilot Study on Anticoagulation Adherence. JMIR formative research 2026. link 82 de Lucena LA, Duarte AG, Hespanhol LC, Muniz J, Félix N, Medeiros K et al.. Reduced vs full-dose direct oral anticoagulants for extended treatment of cancer-associated venous thromboembolism: a systematic review and meta-analysis of randomized trials. Journal of thrombosis and haemostasis : JTH 2026. link 83 Tang W, Li A, Austin TR, Brækkan SK, Nøst TH, Li X et al.. Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism. Circulation 2026. link 84 Bricker J, Ferenz S, Moradian S, Termanini K, Jackson B, Whitney A et al.. Apixaban (Eliquis) for Venous Thromboembolic Prophylaxis following Abdominoplasty: Establishing a Safety and Efficacy Profile. Plastic and reconstructive surgery 2026. link 85 Martin KA, Sparks AD, Wilkinson K, Packer R, Poston JN, Terrell DR et al.. Impact of hospital-acquired venous thromboembolism on surviving a medical admission: findings from the Medical Inpatient Thrombosis and Hemostasis Study. Journal of thrombosis and haemostasis : JTH 2026. link 86 Zhang T, Chen Z, Fu H. Risk Factors for Postoperative Venous Thromboembolism in Patients With Gynecologic Malignancies: A Meta-analysis. American journal of clinical oncology 2026. link 87 Ochiai S, Ono H, Shimizu A, Togi S, Ura H, Niida Y. A Case of Multifocal Venous Malformation With Two Somatic Pathogenic Variants in the TEK Gene. The Journal of dermatology 2026. link 88 Huibonhoa RMT, Raffini L, Sochet AA, Chiusolo F, Nossair F, Tripathi S et al.. Perceived relative clinical significance of the risks of venous thromboembolism and bleeding from pharmacologic thromboprophylaxis in children: an international survey of pediatric providers: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. Journal of thrombosis and haemostasis : JTH 2026. link 89 Teymoori S, Dezfouli M, Feizi A, Hashemi H, Shirzadi M. Association between elevated plasma levels of factor VIII and risk of recurrent venous thromboembolism: a systematic review and meta-analysis. Journal of thrombosis and thrombolysis 2026. link 90 Cheng R, Tang X, Huang X, Dong X, Chen Y, Gao J et al.. Estrogen upregulates lactoferrin to induce hypercoagulability for hemostatic protection during pregnancy. Blood 2026. link 91 Jiang X, Liu H, Yang X, Ma G, Lin X, Hu L et al.. Severe diffused glans penis venous malformation: successful management with 'fractional' Long-pulsed Nd: YAG laser therapy. The Journal of dermatological treatment 2026. link 92 Djulbegovic B, Greenberg C. How to determine the optimal duration of anticoagulation for VTE: an evidence-based decision-analytical approach. Blood advances 2026. link 93 Zeng R, Chang H, Feng G, Guo Q. Intermittent Pneumatic Compression to Prevent Venous Thromboembolism in Critically Ill Adult Patients. American journal of critical care : an official publication, American Association of Critical-Care Nurses 2026. link 94 Frauenheim AC, Wiggins KL, Lemaitre RN, Smith NL, Harrington LB. Physical activity before venous thromboembolism and risk of recurrence in a population-based inception cohort. Journal of thrombosis and thrombolysis 2026. link 95 Zhao Y, Du L, Lin S, Bai L, Chen Y, Ye M et al.. Clinical Phenotype and Genetic Analysis of a Family with Hereditary Antithrombin Deficiency Caused by SERPINC1 Gene Mutation. Thrombosis and haemostasis 2026. link 96 Yamashita Y, Morimoto T, Chatani R, Nishimoto Y, Ikeda N, Kobayashi Y et al.. Newly Diagnosed Cancer After Diagnosis of Venous Thromboembolism　- Insights From the COMMAND VTE Registry-2. Circulation journal : official journal of the Japanese Circulation Society 2026. link 97 Hu X, Zhou D, Su L, Cheng W, Mo L. Risk factors for venous thromboembolism in older patients with malignant solid tumors: A systematic review. Journal of geriatric oncology 2026. link 98 Bruno AM, Allshouse AA, Warrick CM, Metz TD. Single Center Implementation of a Postpartum Pharmacologic Thromboprophylaxis Protocol. American journal of perinatology 2026. link 99 O'Connor C, McIntyre C, Wynne C. Out With the Old, in With the New: Age-Related D-Dimer Thresholds. International journal of laboratory hematology 2026. link 100 Vedovati MC, Talerico R, Sacco C, Mazzetti M, Campello E, Birocchi S et al.. Major Bleeding Risk Assessment in Patients with Cancer-Associated Venous Thromboembolism Treated with DOACs: Data from a Multicenter Cohort. Thrombosis and haemostasis 2026. link